Biblio Discovery — Demo Discovery Service

6 results for "Raheem F. H. Al Aameri"

Showing 1–6 · 1.13 seconds · RSS

  1. Journal Article

    Role of RGS17 in cisplatin-induced cochlear inflammation and ototoxicity via caspase-3 activation

    Raheem F. H. Al Aameri; Entkhab M. A. Alanisi; Dheyaa Al Sallami et al.

    Frontiers in Immunology, Vol. 16 · 2025 · English · DOAJ Scopus

    Cisplatin is a chemotherapy drug used to treat different solid tumors, including ovarian, bladder, lung, and head and neck cancers. One of its significant side effects is ototoxicity, especially when high doses are required. Cisplatin-induced ototoxicity is associated with increased cochlear cell…

  2. Journal Article

    Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss

    Asmita Dhukhwa; Raheem F. H. Al Aameri; Sandeep Sheth et al.

    Scientific Reports, Vol. 11 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Regulators of G protein signaling (RGS) accelerate the GTPase activity of G proteins to enable rapid termination of the signals triggered by G protein-coupled receptors (GPCRs). Activation of several GPCRs, including cannabinoid receptor 2 (CB2R) and adenosine A1 receptor (A1AR), protects…

  3. Journal Article Full text

    Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol

    Raheem F. H. Al Aameri; Sandeep Sheth; Entkhab M. A. Alanisi et al.

    PLOS ONE, Vol. 12 No. 5 · 2017 · English · PLOS Scopus

    Prostate cancer (PCa) is the second leading cause of cancer deaths in men. A better understanding of the molecular basis of prostate cancer proliferation and metastasis should enable development of more effective treatments. In this study we focused on the lncRNA, prostate cancer associated…

    Also available at: DOAJ

  4. Journal Article

    Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity

    Raheem F. H. Al Aameri; Entkhab M. A. Alanisi; Adu Oluwatosin et al.

    Frontiers in Immunology, Vol. 14 · 2023 · English · DOAJ Scopus

    Cisplatin is chemotherapy used for solid tumor treatment like lung, bladder, head and neck, ovarian and testicular cancers. However, cisplatin-induced ototoxicity limits the utility of this agent in cancer patients, especially when dose escalations are needed. Ototoxicity is associated with…